CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong · Delayed Price · Currency is HKD 0.5600
+0.0050 (0.90%)
Sep 11, 2026, 4:08 PM HKT
HKG:0775 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,334 | 7,881 | 3,941 | 5,959 | 7,593 | 7,112 | |
Market Cap Growth | -38.33% | 100.00% | -33.87% | -21.52% | 6.76% | -15.91% |
Enterprise Value | 11,774 | 13,580 | 9,325 | 11,391 | 12,901 | 12,597 |
Last Close Price | 0.56 | 0.82 | 0.41 | 0.62 | 0.78 | 0.72 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 345.44 | 57.54 | 43.69 |
Forward PE | - | 13.75 | 13.75 | 13.75 | 13.75 | 13.75 |
PS Ratio | 0.97 | 1.46 | 0.71 | 1.12 | 1.44 | 1.32 |
PB Ratio | 1.30 | 2.05 | 1.12 | 1.42 | 1.83 | 1.58 |
P/TBV Ratio | 5.61 | 9.51 | 8.01 | 5.76 | 7.79 | 5.66 |
P/FCF Ratio | - | - | 25.10 | 26.31 | 51.43 | 34.30 |
P/OCF Ratio | 37.30 | 42.16 | 11.15 | 11.59 | 20.88 | 16.79 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.13 | 2.51 | 1.69 | 2.14 | 2.45 | 2.33 |
EV/EBITDA Ratio | 50.02 | 431.14 | 38.23 | 29.92 | 32.76 | 31.47 |
EV/EBIT Ratio | - | - | 120.37 | 50.89 | 53.77 | 53.24 |
EV/FCF Ratio | - | - | 59.39 | 50.29 | 87.38 | 60.75 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.67 | 1.72 | 1.74 | 1.42 | 1.43 | 1.38 |
Debt / EBITDA Ratio | 28.98 | 57.93 | 18.91 | 12.96 | 12.63 | 12.85 |
Debt / FCF Ratio | - | - | 38.85 | 26.19 | 40.27 | 29.96 |
Net Debt / Equity Ratio | 1.54 | 1.57 | 1.57 | 1.25 | 1.26 | 1.18 |
Net Debt / EBITDA Ratio | 41.17 | 191.07 | 22.66 | 13.80 | 13.31 | 13.27 |
Net Debt / FCF Ratio | -61.74 | -103.70 | 35.21 | 23.20 | 35.51 | 25.61 |
Asset Turnover | 0.47 | 0.48 | 0.50 | 0.47 | 0.46 | 0.46 |
Inventory Turnover | 3.00 | 3.21 | 3.24 | 2.96 | 2.88 | 2.88 |
Quick Ratio | 0.51 | 0.46 | 0.72 | 0.78 | 0.42 | 0.87 |
Current Ratio | 0.91 | 0.87 | 1.28 | 1.43 | 0.77 | 1.53 |
Return on Equity (ROE) | -2.23% | -5.12% | -3.29% | 0.41% | 3.05% | 3.53% |
Return on Assets (ROA) | -0.06% | -0.72% | 0.44% | 1.24% | 1.30% | 1.25% |
Return on Invested Capital (ROIC) | 0.10% | -1.39% | 0.84% | 0.60% | 1.61% | 1.64% |
Return on Capital Employed (ROCE) | -0.10% | -1.60% | 0.90% | 2.40% | 3.30% | 2.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.21% | -2.37% | -3.21% | 0.29% | 1.74% | 2.29% |
FCF Yield | -1.91% | -0.74% | 3.98% | 3.80% | 1.94% | 2.92% |
Dividend Yield | - | - | - | - | 1.02% | 1.39% |
Payout Ratio | - | - | - | 445.73% | 72.83% | 59.04% |
Total Shareholder Return | - | - | - | - | 1.02% | 1.39% |